santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen
 

Posttranslational Modification Reagents

  • α-Hydroxyfarnesyl-phosphonic acid
    α-Hydroxyfarnesylphosphonic acid potently inhibits farnesyltransferase in isolated enzyme assays and in whole cells.
    Katalog #CAS NummerSummenformelMenge
    sc-200852140633-12-1C15H27O4P1 mg
  • Chaetomellic acid A
    This is a potent inhibitor of farnesyltransferase in isolated enzyme assays (IC50=55nM) but it is inactive in whole cells. Inhibition of farnesyltransferase is selective over geranylgeranyltransferase I and II (IC50=92µM and 34µM respectively).
    Katalog #CAS NummerSummenformelMenge
    sc-221420148796-51-4C19H32O4 ·2Na5 mg/25 mg
  • Farnesyl Thiosalicylic Acid
    A farnesylcysteine mimic, blocks anchorage of Ras proteins to the membrane and to protein escorts. Decreases cellular Ras levels. Inhibits PPMTase methylation of Ras.
    Katalog #CAS NummerSummenformelMenge
    sc-205322162520-00-5C22H30O2S1 mg/5 mg
  • Farnesylpyrophosphate
    Farnesylpyrophosphate is an isoprenoid farnesyl-donor which is utilized by farnesyltransferase.
    Katalog #CAS NummerSummenformelMenge
    sc-20084713058-04-3C15H25O7P2 ·3NH4200 µg/5 mg
  • FPT Inhibitor I
    A highly selective and potent inhibitor of farnesyltransferase. Exhibits inhibition of GGTase I and II at much higher concentrations.
    Katalog #CAS NummerSummenformelMenge
    sc-221625n.n.C19H29NO6P•3Na1 mg
  • FPT Inhibitor II
    A cell permeable potent and selective inhibitor of farnesyltransferase. Is resistant to cleavage by phosphorylation. And inhibits Ras farnesylation in whole cells.
    Katalog #CAS NummerSummenformelMenge
    sc-221626n.n.C17H34NNa2O6P1 mg
  • FPT Inhibitor III
    A cell-permeable prodrug ester form of farnesyltransferase (FTase) inhibitor II. Preventing Ras-mediated transformation by inhibiting Ras processing in cells. Also inhibits C15 and C20 protein prenylation in NIH-3T3 cells.
    Katalog #CAS NummerSummenformelMenge
    sc-221627n.n.C23H39NO7P•Na1 mg
  • FTase Inhibitor I
    A potent, cell-permeable, selective, peptidomimetic inhibitor of FTase. It is ~37-fold more active against FTase than against geranylgeranyltransferase. Is also very resistant to proteolysis.
    Katalog #CAS NummerSummenformelMenge
    sc-221632149759-96-6C22H38N4O3S21 mg
  • FTase Inhibitor II
    A potent FTase inhibitor. Prevents the farnesylation of Ras, which then results in its inability to associate with other cell signaling components in the cell.
    Katalog #CAS NummerSummenformelMenge
    sc-221633n.n.C15H21N3O4S21 mg
  • FTI-2148
    An imidazolo-containing peptidomimetic that preferentially inhibits protein farnesyltransferase activity compared to protein geranylgeranyltransferase-I. Has been shown to disrupt Ras farnesylation in H-Ras-transformed NIH3T3 cells and prevent the growth of T. brucei rhodesiense and T. brucei brucei.
    Katalog #CAS NummerSummenformelMenge
    sc-221634n.n.C24H28N4O3S ·2CF3CO2H500 µg
  • FTI-2628
    A cell-permeable benzyl ester prodrug form of FTI-2148 that preferentially inhibits protein farnesyltransferase activity over protein geranylgeranyltransferase-I. Displays anti-malarial properties. Also suppresses parasitemia in P. berghei-infected mice by 46.1% with no apparent toxicity. Potently disrupts Ras farnesylation in H-Ras-transformed NIH 3T3 cells and inhibits the growth of P. falciparum in red blood cells.
    Katalog #CAS NummerSummenformelMenge
    sc-221635n.n.C31H34N4O3S500 µg
  • FTI-276
    A highly potent and selective CAAX peptidomimetic of the carboxyl terminal of Ras proteins that inhibits FTase in vitro. Inhibits GGTase I at a much higher concentration. Has been shown to selectively block the growth of a human lung carcinoma expressing oncogenic K-Ras in nude mice. Also inhibits oncogenic signaling and tumor growth of NIH 3T3 cells transformed with the Ras oncogene at 20 µM.
    Katalog #CAS NummerSummenformelMenge
    sc-221636n.n.C21H27N3O3S2250 µg
  • FTI-276 trifluoroacetate salt
    A highly potent RasCAAX peptidomimetic which antagonizes both H and K-Ras oncogenic signaling. This compound inhibits farnesyltransferase (Ftase) in vitro with an IC50 of 500 pM. Used as an anti-cancer agent.
    Katalog #CAS NummerSummenformelMenge
    sc-215057170006-72-1 (non-salt)C23H28F3N3O5S21 mg/5 mg
  • FTI-277 trifluoroacetate salt
    Inhibitor of farnesyltransferase (Ftase). Highly potent (pM/nM) Ras CAAX peptidomimetic which antagonizes both H and K-Ras oncogenic signaling.
    Katalog #CAS NummerSummenformelMenge
    sc-215058170006-73-2 (free base)C22H29N3O3S2 ·xC2HF3O21 mg/5 mg
  • Geranylgeranylpyrophosphate triammonium salt
    Geranylgeranylpyrophosphate is a geranylgeranyl-donor molecule which is utilized by geranylgeranyltransferase for isoprenylation of target proteins.
    Katalog #CAS NummerSummenformelMenge
    sc-2008496699-20-3 (non-salt)C20H36O7P2•3NH3200 µg
  • GGTI-2133
    A cell-permeable non-thiol peptidomimetic that acts as a potent and selective inhibitor of GGTase I with a 140-fold selectivity relative to FTase.
    Katalog #CAS NummerSummenformelMenge
    sc-221668n.n.C27H28N4O3250 µg
  • GGTI-2147
    A cell-permeable non-thiol peptidomimetic that acts as a strong and selective inhibitor of GGTase I. Blocks the geranyl-geranylation of Rap1A with an IC50 value that is over 60-fold lower than that required to disrupt the farnesylation of H-Ras.
    Katalog #CAS NummerSummenformelMenge
    sc-221669n.n.C28H30N4O3250 g
  • GGTI-286
    A potent, cell-permeable, and selective inhibitor of GGTase I. This methyl ester derivative of GGTI-287 is about 25-fold more potent than FTI-277 in inhibiting the processing of the geranylgeranylated protein Rap1A. GGTI-286 has also been shown to have a significant antiproliferative effect in human malignant glioma cells. It also selectively antagonizes oncogenic K-Ras4B.
    Katalog #CAS NummerSummenformelMenge
    sc-221670171744-11-9C23H31N3O3S250 µg
  • GGTI-287
    A highly potent and selective peptidomimetic inhibitor of GGTase I than FTase in vitro.
    Katalog #CAS NummerSummenformelMenge
    sc-221671n.n.C22H29N3O3S250 µg
  • GGTI-297
    A potent, cell-permeable, and selective peptidomimetic inhibitor of GGTase I compared to FTase
    Katalog #CAS NummerSummenformelMenge
    sc-221672n.n.C26H31N3O3S250 µg/1 mg
  • L-744,832 Dihydrochloride
    Ras farnesyltransferase inhibitor. Induces tumor regression in transgenic mice with multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis1. Induces p21 expression and arrests cells at G12. Causes enhanced mitotic sensitivity to taxol3.
    Katalog #CAS NummerSummenformelMenge
    sc-2218001177806-11-9 (free acid)C26H45N3O6S2•2HCl5 mg/25 mg
  • Manumycin A
    An antibiotic generated by Streptomyces parvulus that acts as a selective and vigorous inhibitor of Ras farnesyltransferase.
    Katalog #CAS NummerSummenformelMenge
    sc-20085752665-74-4C31H38N2O71 mg
  • N-Acetyl-S-farnesyl-L-cysteine (AFC)
    AFC specifically inhibits the S-farnesylcysteine methyl transferase in cell free extracts and in whole cells.
    Katalog #CAS NummerSummenformelMenge
    sc-200839135304-07-3C20H33NO3S5 mg/25 mg
  • N-Acetyl-S-geranyl-L-cysteine (AGC)
    AGC is a close structural analog of AFC and AGGC but is biologically inactive. It may be used as a negative control for either AFC1 or AGGC2.
    Katalog #CAS NummerSummenformelMenge
    sc-221983n.n.C15H25NO3S5 mg/25 mg
  • N-Acetyl-S-geranylgeranyl-L-cysteine (AGGC)
    Shown to inhibit Ras carboxyl methylation which causes a decrease in cell proliferation. Also noted to be a competitive inhibitor for prenylcysteine methyl transferase.
    Katalog #CAS NummerSummenformelMenge
    sc-200843139332-94-8C25H41NO3S5 mg/25 mg
  • Perillic Acid
    Shown to elicit cytotoxicity, induce cell cycle arrest, and apoptosis via an increase in expression of p21, Bax, and caspase-3 in cells. Also has been reported to be a major metabolite of d-limonene.
    Katalog #CAS NummerSummenformelMenge
    sc-20084123635-14-5C10H14O2100 mg/500 mg
  • 2-PCPA (hydrochloride)
    Histones contain unstructured N-terminal residues that are the site of numerous post-translational modifications, involving acetylation, ubiquitination, methylation, and sumoylation to produce a specific gene regulatory outcome.
    Katalog #CAS NummerSummenformelMenge
    sc-220762n.n.C9H12ClN10 mg/5 mg
  • S-Farnesyl-L-cysteine Methyl Ester
    Stimulates the multidrug resistance transporter ATPase activity (4-5-fold at 10-20 µM) and competes for drug binding.
    Katalog #CAS NummerSummenformelMenge
    sc-222275n.n.C19H33NO2S5 mg/25 mg